← SynDRA
GEFAPIXANT
SynDRA canonical compound SYN0038527 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
| Primary target(s) | P2RX3 |
| Mechanism of action | purinergic receptor antagonist |
All known targets
Mechanisms of action (all sources)
- P2RX3 ANTAGONIST
- P2X purinoceptor 3 antagonist
- purinergic receptor antagonist
- P2RX3 INHIBITOR
ATC classes
- R05D · COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS
Cross-references
Synonyms
- gefapixant citrate
- lyfnua
- AF-219
- RO4926219
- MK-7264
- R-1646
- R1646
- RG-1646
- RG1646
- RO-4926219
- UNII-6K6L7E3F1L
- 6K6L7E3F1L
- Gefapixant [USAN]
- GTPL9540
- SCHEMBL1493905
- CHEMBL3716057
- HLWURFKMDLAKOD-UHFFFAOYSA-N
- ZINC116342482
- J3.556.891C
- 5-(2,4-diaminopyrimidin-5-yl)oxy-2-methoxy-4-propan-2-ylbenzenesulfonamide
- 2-Methoxy-4-isopropyl-5-(2,4-diamino-5-pyrimidinyloxy)benzenesulfonamide
- 5-(2,4-diamino-pyrimidin-5-yloxy)-4-isopropyl-2-methoxy-benzenesulfonamide
- 5-((2,4-Diaminopyrimidin-5-yl)oxy)-2-methoxy-4-(propan-2-yl)benzenesulfonamid
- Ro-4926219
- gefapixantum
- RefChem:639790
- DTXCID601767631
- MFCD24539325
- C14H19N5O4S
- MK-7264;AF-219
- Lyfnua
- AF9
- Gefapixant (Standard)
- GEFAPIXANT [INN]
- Gefapixant (USAN/INN)
- GEFAPIXANT [WHO-DD]
- orb1302092
- SCHEMBL30094221
Look up GEFAPIXANT in the interactive SynDRA portal →